MENU
APGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apogee Therapeutics (APGE) Ownership - Who owns Apogee Therapeutics?
Profile
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.71B
P/E Ratio
N/A
Total Cash
526.05M
Projected Growth
N/A
Total Debt
12.14M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.24
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APGE
Capitalization
2.72B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
526M
Total Cash/Share
9.24
Total Debt
12.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
734M
P/B Ratio
3.70
Cash Flow
N/A
Earnings
-2.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
16.39
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-169.13M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.39
Shares Held By Institutions
4.38B
Shares Outstanding - Current
56.9M
Total Liabilities
41.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
70.759
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com